Cyril Fersing

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Venues

Pharmaceutics

Current radiopharmaceuticals

International journal of molecular sciences

Medicina (Kaunas, Lithuania)

Institut de Recherche en Cancérologie de Montpellier

Aix-Marseille Université Faculte des Sciences (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de Recherche en Cancérologie de Montpellier Nov 02 2018

France

Teaching hospital assistant lecturer :: INSERM U1194 - Radiobiology and Vectorized Radiotherapy team

Institut régional du Cancer de Montpellier Nov 02 2018

France

Teaching hospital assistant lecturer :: Nuclear Medecine/Radiopharmacy

Assistance Publique - Hôpitaux de Marseille Nov 02 2013 - Oct 31 2018

France

Pharmacy Intern :: Pharmacy, oncopharmacy, radiopharmacy

Institut de Chimie Radicalaire Sep 01 2014 - Jul 11 2018

France

PhD candidate :: Medicinal Chemistry

Assistance Publique - Hôpitaux de Marseille Nov 02 2012 - Aug 31 2013

France

Pharmacy student :: Radiopharmacy

Education History

Aix-Marseille Université Faculte des Sciences Sep 01 2013 - Jun 30 2014

France

MSC :: Organic Chemistry

Publications

Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68 Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. Current radiopharmaceuticals 17 (3) (2024)
Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68 Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. Current radiopharmaceuticals 17 (3) (2024)
Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68 Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. Current radiopharmaceuticals 17 (3) (2024)
Juliette Fouillet, Charlotte Donzé, Emmanuel Deshayes, Lore Santoro, Léa Rubira, Cyril Fersing
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant 68Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617. Current radiopharmaceuticals (2024)
Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Emmanuel Deshayes, Cyril Fersing, Constance Thibault, Mathieu Roumiguie, Philippe Pourquier, Nadine Houédé
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices. Cancers 15 (12) (2023)
Céleste Souche, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Emmanuel Deshayes, Cyril Fersing
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. International journal of molecular sciences 25 (1) (2023)
Céleste Souche, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Emmanuel Deshayes, Cyril Fersing
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. International journal of molecular sciences 25 (1) (2023)
Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
225 Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic. Pharmaceutics 15 (4) (2023)
Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
225 Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic. Pharmaceutics 15 (4) (2023)
Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
225 Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic. Pharmaceutics 15 (4) (2023)
Emmanuel Deshayes, Cyril Fersing, Constance Thibault, Mathieu Roumiguie, Philippe Pourquier, Nadine Houédé
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices. Cancers 15 (12) (2023)
Céleste Souche, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Emmanuel Deshayes, Cyril Fersing
Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy. International journal of molecular sciences 25 (1) (2023)
Léa Rubira, Emmanuel Deshayes, Lore Santoro, Pierre Olivier Kotzki, Cyril Fersing
225 Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic. Pharmaceutics 15 (4) (2023)
Marie-Claude Eberlé, Cyril Fersing, Sophie Guillemard, Diana Ilonca, Séverine Guiu, Emmanuel Deshayes
Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean? Diagnostics (Basel, Switzerland) 12 (4) (2022)
Charlotte Donzé, Léa Rubira, Lore Santoro, Malissone Viarasakd, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing
177 Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods. European journal of hospital pharmacy : science and practice (2022)
Cyril Fersing, Nicolas Masurier, Léa Rubira, Emmanuel Deshayes, Vincent Lisowski
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Charlotte Donzé, Léa Rubira, Lore Santoro, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing
Development and Implementation of a Professional Practices Evaluation during Radiopharmaceuticals Administration. Healthcare (Basel, Switzerland) 10 (11) (2022)
Prisca Lagardère, Cyril Fersing, Nicolas Masurier, Vincent Lisowski
Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Cyril Fersing, Emmanuel Deshayes, Sarah Langlet, Laurence Calas, Vincent Lisowski, Pierre Olivier Kotzki
Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators. EJNMMI radiopharmacy and chemistry 6 (1) (2021)
Cyril Fersing, Ahlem Bouhlel, Christophe Cantelli, Philippe Garrigue, Vincent Lisowski, Benjamin Guillet
A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? Molecules (Basel, Switzerland) 24 (16) (2019)

Cyril Fersing.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cyril Fersing